The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $71,766,855 in first-year total cost, median $5,352,080.
Most frequent study sections
- Special Emphasis Panel[ZAI1 LR-M (J1)]14
Most frequent institutions
- HARVARD MEDICAL SCHOOL3
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- RBHS-NEW JERSEY MEDICAL SCHOOL1
- SCRIPPS RESEARCH INSTITUTE, THE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents1U19AI109725-01 | VIRGIN, HERBERT W | WASHINGTON UNIVERSITY, MO | $6,377,610 | ZAI1 |
| 2014 | Antiviral Drug Discovery and Development Center - Overall1U19AI109680-01 | WHITLEY, RICHARD J. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $6,270,702 | ZAI1 |
| 2014 | Center for Research in Diagnostics and Discovery1U19AI109761-01 | LIPKIN, W. IAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $6,269,460 | ZAI1 |
| 2014 | Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers1U19AI109762-01 | SAPHIRE, ERICA OLLMANN | SCRIPPS RESEARCH INSTITUTE, THE, CA | $5,997,620 | ZAI1 |
| 2014 | Integrated discovery and development of innovative TB Diagnostics1U19AI109755-01 | MURRAY, MEGAN B | HARVARD MEDICAL SCHOOL, MA | $5,956,642 | ZAI1 |
| 2014 | Advancement of Treatments for Ebola and Marburg Virus Infections1U19AI109711-01 | GEISBERT, THOMAS WILLIAM | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $5,687,856 | ZAI1 |
| 2014 | Center to develop therapeutic countermeasures to high-threat bacterial agents1U19AI109713-01 | PERLIN, DAVID S | RBHS-NEW JERSEY MEDICAL SCHOOL, NJ | $5,399,115 | ZAI1 |
| 2014 | Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic1U19AI109662-01 | GLENN, JEFFREY S | STANFORD UNIVERSITY, CA | $5,305,044 | ZAI1 |
| 2014 | Innovative Platforms for Antimicrobial Therapy and Vaccine Development1U19AI109764-01 | KASPER, DENNIS L. | HARVARD MEDICAL SCHOOL, MA | $4,937,887 | ZAI1 |
| 2014 | Immunoprophylactic Strategies to Control Emerging Enteric Infections1U19AI109776-01 | LEVINE, MYRON MAX | UNIVERSITY OF MARYLAND BALTIMORE, MD | $4,894,397 | ZAI1 |
| 2014 | Small molecule inhibitors of enveloped virus entry1U19AI109740-01 | WHELAN, SEAN PJ | HARVARD MEDICAL SCHOOL, MA | $4,422,325 | ZAI1 |
| 2014 | Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants1U19AI109784-01 | TING, JENNY P | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $3,603,126 | ZAI1 |
| 2014 | Antimicrobial Drug Discovery from Coevolved Symbiotic Communities1U19AI109673-01 | ANDES, DAVID RCURRIE, CAMERON ROBERT | UNIVERSITY OF WISCONSIN-MADISON, WI | $3,433,302 | ZAI1 |
| 2014 | Therapeutics Targeting Filoviral interferon-antagonist and replication functions1U19AI109664-01 | BASLER, CHRISTOPHER F | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $3,211,769 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.